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Supplementary Figure 1. Only prophylactic oral administration of PSA protects against HSE in 
a murine model with delayed ACV treatment.  
(a) HSV infected 129 WT mice were given ip injections of ACV (1.25 mg/mouse) or PBS (CTRL) 
from the indicated time points for a week and monitored for HSE symptoms and survival (n=8-
18 mice per group). HSV infected 129 WT mice given ACV from day 4 pi for a week by ip 
injections were also treated with PSA (50µg) or PBS by (b) ip, iv or oral (po) routes on days 1, 2 
and 4 pi or (c) were pre-treated with 6 doses of PSA or PBS by ip or iv injections and monitored 
for survival, (n=6-8 mice per group, ns-not significant). (d) Another group of WT mice were pre-
treated with PSA by the ip, iv or oral (po) routes but not given ACV after infection (n= 9-13 / 
group), ns=not significant. (e) PBS treated naïve Rag mice that were adoptively transferred with 
WT CD4 or CD8 T cells or WT B cells or WT B + T cells or IL-10KO B + T cells were infected with 
HSV and given daily ACV injections for a week starting on day 4 pi, (n= 6-12), ns= not significant. 
All statistical analysis was performed using log rank Mantel Cox survival test. See Figures 1 and 
5. 
  
Supplementary Figure 2. 
 
 
 
 
Supplementary Figure 2. Gating Strategy for analysis of cells in the brainstem (BS), lymph 
nodes and spleen.  
(a) Mononuclear cells (live, singlets) isolated from the BS of infected mice at day 6 pi were 
analyzed for CD45 expression (left); CD45high gated cells were analyzed for CD11b+ myeloid cells 
(left middle); CD45highCD11b+ gated cells were analyzed for MHC II and Ly6C expression to 
determine IM (right middle), PMN are MHC II- Ly6Cint Ly6G+; CD45high gated cells were analyzed 
for degranulation of CD11b+ cells by surface CD107a+b expression (right plot). This gating 
strategy was used to identify cells in the BS of WT and Rag mice and shown in Figure 2, 4e-f, 5d-
e and Supplementary Figures 5c. (b) Mononuclear live singlet cells isolated from lymph nodes 
(LN: left plot) and spleen (middle plot) gated using lymphocyte gate were analyzed for B220 and 
CD3 expression, B220+ gated cells were confirmed for CD19 expression (top right); CD3+ gated T 
cells were analyzed for CD4 and CD8 expression (bottom panel). This gating strategy was used 
to identify and enumerate cells in LN and spleens of WT mice in Figures 3, 4a-b, 6c-e and 
Supplementary Figures 2c, 3, 4c-d, 5a-b, 5d, 7, 8b-c and 10.  (c) T cells from LN (top) and spleen 
(bottom) were gated on CD4 (left plot) or CD8 (middle plot) shown above in (b) and analyzed 
for CD73 and CD62L or ICOS and CD39 (right plot: CD4); See Figures 2 and 3. 
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Supplementary Figure 3. PSA increases expansion of antigen specific T cells in lymphoid 
organs.  
The draining cervical LN (CLN) isolated at day 6 pi from PSA or PBS pre-treated HSV infected, 
ACV treated WT mice were analyzed for accumulation of (a) CD8 T cells reactive to HSV gB498-505 
tetramer (gB Tet) and CD62L expression (top panel) or CD73 (bottom panel), (b) CD4 T cells 
expressing CD11a (as a surrogate marker for antigen experience) and CD62L (top panel) or 
CD73 (bottom panel). Naïve CD4 T cells do not express CD11a. (c) Mononuclear cells isolated 
from Lamina Propria (LP) at day 6 pi gated on CD45+ CD8+ T cells were analyzed for HSV gB498-505 
tetramer reactivity (gB Tet) and CD44 expression, and (d) CD45+ cells were analyzed for plasma 
cells as determined by CD138 and B220low phenotype. (e) Bar plots shows total numbers of CD4 
and CD8 T cells in the CLN of HSV infected 129 WT mice treated with PBS or PSA and 129 BKO 
mice treated with PSA (n=6 mice). All data show mean +/- SEM. (See Figure 3 and 4).   
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Supplementary Figure 4. Cytokine and Chemokine expression in the CNS and lymphoid 
organs.  
(a) Cytokine and (b) chemokine expression in the BS of PSA (blue) or PBS (red) treated mice 
(n=3) at day 6 post HSV infection relative to uninfected mice (day 0); all mice were given ACV 
from day 4 pi. (c) Splenocytes were isolated at day 6 pi from PSA or PBS pre-treated HSV 
infected ACV treated WT mice and analyzed for intracellular IFNg and IL-10 secretion following 
PMA and Ionomycin stimulation for 5 hours. Flow cytometry plots show CD8 (left) and CD4 
(middle) T cell and B cell (right) gated cells. (d) Bar plots show CD4 (left) and CD8 T cells 
(middle) and B cells (right) isolated from spleens and MLN of WT mice treated with 6 doses of 
PSA orally that were analyzed prior to HSV infection for IL-10 and IFNg secretion, n=2 
experiments. All data show mean +/- SEM. See Figure 4. 
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Supplementary Figure 5. PSA requires B cells to induce IL-10 secreting CD4 T cells.  
(a) Flow cytometry plots show (left plot) complete depletion of CD19+ B cells but not T cells 
(CD5+) in the spleens of BKO mice at day 6 pi. To deplete B cells, WT mice were treated with 
aCD20 mAb given by ip injection every 10 days, beginning prior to PSA treatment and 
continued throughout infection (see also Fig. 5b). (b) Intracellular IFNg and IL-10 expression by 
CD4 (middle plot) and CD8 (right plot) T cells isolated from spleens of BKO mice at day 6 pi 
following 5 hr stimulation with PMA + Ionomycin. (c) Bar plots show % CD45high cells infiltrating 
the BS of Rag recipients of WT B + T cells (blue), IL10KO B + T cells (magenta), WT B + IL10KO T 
cells (green) and IL10KO B + WT T cells (brown) at day 6 pi (see Fig. 5d-e), *p<0.05, **p<0.01, 
****p<0.0001, as determined by ordinary one way ANOVA with Turkeys multiple comparisons 
tests. All data show mean +/- SEM. (d) Flow cytometry plots of spleens taken at day 6 pi from 
129 Rag recipient mice of mixed transfers of IL-10KO B + WT T cells (top row: brown circle) and 
WT B + IL10KO T cells (bottom row: green circle) that were pre-treated with PSA prior to HSV 
infection show CD44 expression by (left plot) CD4 T cells and ICOS or (right plot) virus specific 
CD8 T cells reactive to HSV gB498-505 tetramer (See Figure 5d-e). 
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Supplementary Figure 6. PSA binding studies for gut resident B cells and IL-10 secretion by WT 
but not Rag gut cells.  
(a) Gating strategy used to analyze Ileal CD45+ mononuclear singlet IEL cells (left plot) to show 
CD45 B220+ B cells, B220+ CD11c+ pDCs and B220- CD11c+ cDCs (left middle plot). cDCs were 
confirmed by expression of CD11b (right middle histogram) while pDCs were confirmed by 
pDCA1 expression (right histogram). The gating strategy shown in a was used to identify 
immune cell types in the duodenum and ileum of WT and Rag mice as shown in Figure 6 and 
Supplementary Figures 6, 8a and 9b-c. (b) Gating strategy used to analyze Ileal CD45+ 
mononuclear singlet cells to show B220+ cells with MHC II expression (top) and B220+, B220low 
and B220- cells (bottom). (c) Gated populations represented by numbers 1-5 from the top and 
bottom plots in (b) were analyzed for binding to PSA, numbers show % PSA reactive while 
numbers in parenthesis show intensity of binding to PSA as denoted by MFI. (d) CD45+ singlet 
mononuclear cells isolated from duodenum (Duod: top) and ileum (Ile: bottom) were gated on 
B cells, CD138+ PCs and PDCA1+B220+ pDCs as shown in (a) and analyzed for binding to PSA. (e) 
CD45+ IEL isolated from Duod of Rag (blue line) and WT (red line) mice (left 2 plots) showing IL-
10 or (f) IL-17 secretion; (g) IL-17 secretion by Ile CD45+ IEL (left) and PP cells (right) isolated 
from Rag-/- mice following stimulation with PSA (blue line) or PMA + Ionomycin (P+I: red line). 
See Figure 6.  
 
 
  
Supplementary Figure 7. 
 
Supplementary Figure 7. PSA binding studies by spleen subsets.  
(a), Top row, left histogram: Splenocytes from naïve WT mice were analyzed for binding to 
fluorescent conjugated PSA after pre-blocking with unlabeled PSA (yellow line) or PBS (blue 
line). Unlabeled cells: red line. Gating strategy to distinguish (b) B220+ B cells and 
CD138+B220low plasma cells (PC), (c) B220+PDCA1+CD11c+ pDCs subsets (see arrows for primary 
gate) were analyzed for binding to PSA in (d) B cells (left) and PC (right), and (e) pDC. Gating 
strategy to analyze Innate cells including (f) CD11b+SSChighLy6G+ PMN and SSClowCD11b+ 
monocytes and (g) SSClowCD11b+ gated F480+CD11b+ macrophages (Macs) and 
SSClowGr1highF480- IM (right plot). (h) Gated populations from plots f and g (see arrows for 
primary gate) were analyzed for PSA binding in h. This gating strategy was also used to identify 
spleen cell populations in Supplementary Figure 8b-c. 
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Supplementary Figure 8. TLR2 expressing cells bind PSA.  
(a) Mononuclear live singlet cells isolated from duodenum of WT mice were analyzed for TLR2 
and CD45 expression (left plot). CD45+ TLR2+ gated IEL cells were analyzed for CD11c, B220 and 
CD11b expression (middle plot); Gates show CD11c+B220- cDCs, B220+CD11c+ pDCs, 
B220+CD11c-CD19+ B cells + PB and B220-CD11c-CD11b+ macrophages which were probed for 
binding to PSA (right plot), see Supplementary Figure 6a for gating strategy. TLR2+ CD45- IEC 
(left plot) were also probed for binding to PSA in the right plot. (b-c) Various spleen cell subsets 
including B220- CD11c+ cDCs, PDCA1+CD11c+ pDCs, SSClow CD11b+ monocytes/macs, SSChigh 
CD11b+ PMN, CD3+ T cells and B220+CD19+ B cells from (b) BALB/c WT and (c) SIGNR1KO mice 
were probed for TLR2 (left) and TLR4 (right) expression, see Supplementary Figure 7 for gating 
strategy. 
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 Supplementary Figure 9. Depletion of pDCs or SIGNR1 does not alter PSA mediated 
protection.   
(a) WT mice were depleted of pDCs using anti-PDCA1 mAb prior to PSA pretreatment, and 
continued through HSV infection, mAb given every 3-4 days throughout experiment, n=10-12, 
ns=not significant. (b) IEL isolated from duodenum (Duod) of WT or SIGNR1-/- mice were 
analyzed for binding to PSA-A488. (c-d) pDCs (left), PB (middle) and F480+CD11c- macrophages 
(right) in the IELs isolated from (c) Duod and (d) Ile of WT (red line) and SIGNR1-/- (blue line) 
mice were analyzed for reactivity to PSA-A488. (e) SIGNR1KO or WT littermates were pre-
treated with PSA or PBS as in Fig. 1a, infected with HSV 17+ (8x104 PFU) by corneal scarification 
and treated with ACV from day 4 pi for one week; mice were monitored for symptoms of HSE 
and mortality (n=8-12), *p<0.05 as determined by log rank Mantel Cox test.  
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Supplementary Figure 10. T cell derived IL-10 essential for accumulation of plasma cells in the 
LN.  
(a) Plasma cell (CD138+B220- PC) and plasmablast (CD138+B220+ PB) accumulation in the 
spleens (top) and MLN (bottom) of WT mice prior to PSA treatment (left), after one week with 3 
doses (1: middle) and after 2 weeks with 6 doses (2: right plot). Blue box labeled PC shows 
plasma cells and green box shows plasmablasts (PB). (b) Accumulation of PC and PB at day 6 pi 
in spleens of Rag recipients of WT B + T cells (WT: blue), IL10KO B + WT T cells (WT T: brown), 
WT B + IL10KO T cells (IL10KO T: green), and IL10KO B + T cells (IL10KO: magenta) that had been 
given 6 doses of PSA prior to HSV infection and ACV treatment. See Figure 5 for key to symbols.    
 
 
